June 23, 2024


Built General Tough

Biotech’s trust issues, overwhelmed health workers, & the nuances of insider trading

Why is the FDA so shy about rejection? How are health workers holding up in Louisiana? And when will conferences be safe again?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. First, we discuss a sudden spike of FDA rejections, which has resurfaced a time-honored frustration: You can’t always trust biotech companies to be honest about their conversations with the agency. Then, STAT’s Lev Facher joins us to share his reporting from Louisiana, where a surge of Covid-19 deaths among the unvaccinated is having devastating effects on health workers. Before that, we talk about a curious case of alleged insider trading, medical conferences in the time of Delta, and the global vaccine push.

For more on what we cover, here’s the story on Sesen Bio; here’s more from Louisiana; here’s where you can subscribe to the First Opinion Podcast; and here’s our complete coverage of the Covid-19 pandemic.


Be sure to sign up on Apple PodcastsStitcherGoogle Play, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].


Interested in sponsoring a future episode of “The Readout LOUD”? Email us at [email protected].